慢性肝病与血小板减少：临床处理观念的转变

doi:10.3969/j.issn.1672-5069.2019.04.001

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (4): 457-458.doi: 10.3969/j.issn.1672-5069.2019.04.001

• 述评 • 下一篇

慢性肝病与血小板减少：临床处理观念的转变

唐承薇

610041 成都市四川大学华西医院消化内科

收稿日期:2019-04-17 出版日期:2019-07-10 发布日期:2019-07-19
作者简介:唐承薇,教授。Tel：86 28 85422383（O）,E-mail: shcqcdmed@163.com

Chronic liver disease and thrombocytopenia：Changes in clinical management concept

Tang Chengwei

Department of Gastroenterology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China

Received:2019-04-17 Online:2019-07-10 Published:2019-07-19

摘要/Abstract

关键词: 慢性肝病, 血小板减少症, 新观念

Key words: Chronic liver disease, Thrombocytopenia, Management, New concept

唐承薇. 慢性肝病与血小板减少：临床处理观念的转变[J]. 实用肝脏病杂志, 2019, 22(4): 457-458.

Tang Chengwei. Chronic liver disease and thrombocytopenia：Changes in clinical management concept[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 457-458.

[1] Humbrecht C,Kientz D,Gachet C.Platelet transfusion: Current challenges. Transfus Clin Biol. 2018,25(3):151-164.
[2] 文良志,熊吉,孙文静,等. 肝硬化与骨髓造血.实用肝脏病杂志,2017,20(4):391-393.
[3] Saab S,Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci.2019 Apr 22. doi:10.1007/s10620-019-05615-5.[Epub ahead of print]
[4] Mitchell O,Feldman DM,Diakow M,et al.The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016,8:39-50.
[5] 中华医学会肝病学分会、消化病学分会、内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志,2016,19(5):I-XVI.
[6] 陈世耀,黄晓铨,曾晓清.门静脉高压症的检查选择与病因诊断.实用肝脏病杂志,2018,21(3):321-324.
[7] 姚小健,黄红霞,陈勇. 乙型肝炎肝硬化患者血清血小板衍生生长因子和叶酸水平变化. 实用肝脏病杂志,2018,21(1):76-79.
[8] 汤诗杭,高锦航,唐承薇. 环氧合酶在肝硬化门静脉高压中的作用和机制. 中华消化杂志,2017,37(10):717-720.
[9] Luo X,Nie L,Wang Z,et al.Transjugular endovascular recanalization of splenic vein in patients with regional portal hypertension complicated by gastrointestinal bleeding. Cardiovasc Intervent Radiol. 2014,37(1):108-13.
[10] Tang Y,Zheng S,Yang J,et al.Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients. Medicine(Baltimore). 2017,96(49):e8678.
[11] Gao JH,Wen SL,Tong H,et al.Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats. Am [J] Physiol Gastrointest Liver Physiol. 2016,310(11):G962-72.
[12] Gao JH,Wen SL,Feng S,et al.Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis. 2016,19(4):501-11.
[13] Wen SL,Gao JH,Yang WJ,et al.Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. [J] Gastroenterol Hepatol. 2014,29(11):1932-42.
[14] Gao JH,Wen SL,Yang WJ,et al.Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS One. 2013,8(7):e69309.

慢性肝病与血小板减少：临床处理观念的转变

Chronic liver disease and thrombocytopenia：Changes in clinical management concept

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

[1]	王艳欣综述, 于红卫, 朱跃科审校. 慢性肝病的营养评估与治疗*[J]. 实用肝脏病杂志, 2018, 21(2): 317-320.
[2]	陈柳莹, 陆伦根. 重视慢性肝病的病情评估[J]. 实用肝脏病杂志, 2017, 20(1): 4-6.
[3]	曾静, 范建高. 脾脏硬度检测在慢性肝病无创诊断中的应用^*[J]. 实用肝脏病杂志, 2015, 18(2): 209-212.
[4]	王柏芳, 王, 颖, 王炳元, 王, 菲, 李雪华. 异甘草酸镁对慢性肝病实验室指标改善的价值^*[J]. 实用肝脏病杂志, 2012, 15(3): 235-237.
[5]	魏屏,张建傲,揭盛华,贺永文. 门冬氨酸鸟氨酸颗粒剂对慢性肝病患者血清谷氨酰转肽酶水平的影响[J]. 实用肝脏病杂志, 2011, 14(6): 422-423.